Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiota

Ulcerative colitis (UC) is a long-term inflammatory disorder that has evolved into a worldwide challenge. The development of new therapies against UC is imperative as all current therapies for UC are flawed in some way. Thus, the present study aimed to assess the palliative effects of Lactobacillus...

Full description

Saved in:
Bibliographic Details
Main Authors: Huizhen Li, Yang Chen, Huiting Fang, Xinmei Guo, Xuecong Liu, Jianxin Zhao, Wei Chen, Bo Yang
Format: Article
Language:English
Published: Tsinghua University Press 2025-06-01
Series:Food Science and Human Wellness
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2024.9250139
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849242740932476928
author Huizhen Li
Yang Chen
Huiting Fang
Xinmei Guo
Xuecong Liu
Jianxin Zhao
Wei Chen
Bo Yang
author_facet Huizhen Li
Yang Chen
Huiting Fang
Xinmei Guo
Xuecong Liu
Jianxin Zhao
Wei Chen
Bo Yang
author_sort Huizhen Li
collection DOAJ
description Ulcerative colitis (UC) is a long-term inflammatory disorder that has evolved into a worldwide challenge. The development of new therapies against UC is imperative as all current therapies for UC are flawed in some way. Thus, the present study aimed to assess the palliative effects of Lactobacillus rhamnosus MP108 on UC in mice and to explore its potential mechanisms. The results showed that L. rhamnosus MP108 ameliorated the symptoms of UC, including preventing body weight loss, disease activity index (DAI) elevation, and colon shortening, and attenuated colonic pathological damage. L. rhamnosus MP108 dramatically increased the number of goblet cells, MUC2 level, and tight junction protein level in the colon and remarkably inhibited epithelial cell apoptosis, thereby strengthening the intestinal barrier. L. rhamnosus MP108 pronouncedly diminished pro-inflammatory cytokine levels and strikingly augmented anti-inflammatory cytokine levels, in turn suppressing inflammation. Furthermore, L. rhamnosus MP108 conspicuously boosted the proportion of short-chain fatty acids (SCFAs) producers in gut microbiota, contributing to increased levels of acetate and butyrate. Therefore, L. rhamnosus MP108 might alleviate UC via improving the intestinal barrier, inhibiting inflammation, and modulating intestinal microbiota.
format Article
id doaj-art-7c97a55ca25946129b41d81bf7e07835
institution Kabale University
issn 2097-0765
2213-4530
language English
publishDate 2025-06-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-7c97a55ca25946129b41d81bf7e078352025-08-20T03:59:44ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302025-06-01146925013910.26599/FSHW.2024.9250139Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiotaHuizhen Li0Yang Chen1Huiting Fang2Xinmei Guo3Xuecong Liu4Jianxin Zhao5Wei Chen6Bo Yang7State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, ChinaJinqiao Biotechnology Co., Ltd., Huai’an 223005, ChinaJinqiao Biotechnology Co., Ltd., Huai’an 223005, ChinaState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, ChinaUlcerative colitis (UC) is a long-term inflammatory disorder that has evolved into a worldwide challenge. The development of new therapies against UC is imperative as all current therapies for UC are flawed in some way. Thus, the present study aimed to assess the palliative effects of Lactobacillus rhamnosus MP108 on UC in mice and to explore its potential mechanisms. The results showed that L. rhamnosus MP108 ameliorated the symptoms of UC, including preventing body weight loss, disease activity index (DAI) elevation, and colon shortening, and attenuated colonic pathological damage. L. rhamnosus MP108 dramatically increased the number of goblet cells, MUC2 level, and tight junction protein level in the colon and remarkably inhibited epithelial cell apoptosis, thereby strengthening the intestinal barrier. L. rhamnosus MP108 pronouncedly diminished pro-inflammatory cytokine levels and strikingly augmented anti-inflammatory cytokine levels, in turn suppressing inflammation. Furthermore, L. rhamnosus MP108 conspicuously boosted the proportion of short-chain fatty acids (SCFAs) producers in gut microbiota, contributing to increased levels of acetate and butyrate. Therefore, L. rhamnosus MP108 might alleviate UC via improving the intestinal barrier, inhibiting inflammation, and modulating intestinal microbiota.https://www.sciopen.com/article/10.26599/FSHW.2024.9250139lactobacillus rhamnosusulcerative colitisintestinal barrierinflammationgut microbiota
spellingShingle Huizhen Li
Yang Chen
Huiting Fang
Xinmei Guo
Xuecong Liu
Jianxin Zhao
Wei Chen
Bo Yang
Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiota
Food Science and Human Wellness
lactobacillus rhamnosus
ulcerative colitis
intestinal barrier
inflammation
gut microbiota
title Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiota
title_full Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiota
title_fullStr Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiota
title_full_unstemmed Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiota
title_short Lactobacillus rhamnosus MP108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier, inhibiting inflammation, and modulating gut microbiota
title_sort lactobacillus rhamnosus mp108 alleviates ulcerative colitis in mice by enhancing the intestinal barrier inhibiting inflammation and modulating gut microbiota
topic lactobacillus rhamnosus
ulcerative colitis
intestinal barrier
inflammation
gut microbiota
url https://www.sciopen.com/article/10.26599/FSHW.2024.9250139
work_keys_str_mv AT huizhenli lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota
AT yangchen lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota
AT huitingfang lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota
AT xinmeiguo lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota
AT xuecongliu lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota
AT jianxinzhao lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota
AT weichen lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota
AT boyang lactobacillusrhamnosusmp108alleviatesulcerativecolitisinmicebyenhancingtheintestinalbarrierinhibitinginflammationandmodulatinggutmicrobiota